Navigation Links
knowledge of proliferative sickle cell retinopathy can help Prevent eye trauma

Sickle cell disease is an inherited blood disorder that affects the hemoglobin protein found in red blood cells. Visual loss has been reported in 10- 20% of eyes in patients with this disease, a high figure that // may reflect ascertainment bias towards detecting patients with symptoms. Proliferative sickle cell retinopathy (PSR) is the principal contributor to visual loss, but the patients remain asymptomatic unless traumatic complications such as vitreous hemorrhage or retinal detachment (RD) occur.

A recent study, to be published in the November issue of Ophthalmology, details a longitudinal study done over 20 years to describe the incidence, prevalence, and natural history of proliferative sickle cell retinopathy (PSR) in a patient population free from the bias of symptomatic referral, followed from birth.

This work, supported by the Wellcome Trust, London, United Kingdom, confirms a greater incidence and severity of PSR in sickle cell disease, and shows that spontaneous regression occurred in 32% of PSR-affected eyes. Permanent visual loss was uncommon in subjects observed up to the age of 26 years. The discrepancy between the frequency of PSR, which concerns the ophthalmologist, and that of visual loss, which concerns the patient, raises a note of caution. It calls into question the justification of routine screening and prophylactic treatment, particularly if it is directed towards prevention of permanent visual loss rather than transient loss from hemorrhage.

Knowledge of the natural history of PSR is essential because the prevention of this visual loss and eye trauma is dependent on the early detection and treatment of proliferative sickle cell retinopathy.
'"/>




Page: 1

Related medicine news :

1. Spreading knowledge to doctors about herbal medicine
2. Guidant sold defective defibrillators with full knowledge
3. India set to become the global knowledge hub
4. New law to protect traditional knowledge
5. Zinc may enhance growth in Young sickle cell patients
6. Gene to identify risk of stroke in sickle cell anemia
7. New treatment for babies with sickle cell anemia
8. Diabetic retinopathy in pre-diabetes conditions
9. Lose stomach for Life....Preventive removal of stomach saves the risk of cancer
10. Prevention is better than cure
11. Prevention of cataracts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many of ... beholder, according to experts who offered insights and commentary in the current issue of ... full issue, click here . , For the American Society of Clinical Oncology ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: